QUOTE AND NEWS
StreetInsider.com  Apr 29  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Arrowhead+%28ARWR%29+Prices+14.3M+Common+Stock+Offering/8286917.html for the full story.
StreetInsider.com  Mar 25  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Arrowhead+Research+%28ARWR%29+Stock+Moves+Higher+Ahead+of+Analyst+Event/8208366.html for the full story.
Benzinga  Mar 25  Comment 
Arrowhead Research Corporation (NASDAQ: ARWR) will host an analyst event today in New York City to discuss ARC-520, its RNAi-based candidate designed to treat chronic hepatitis B virus infection. The company will discuss the program...
Benzinga  Feb 28  Comment 
Arrowhead Research Corporation (NASDAQ: ARWR), a targeted therapeutics company, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Number 13/336,028 entitled, “In...
StreetInsider.com  Jan 25  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Arrowhead+Research++%28ARWR%29+to+Offer+1.65M+Common+at+%242.12Share/8031807.html for the full story.
StreetInsider.com  Jan 24  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Arrowhead+Research+%28ARWR%29+Plans+Common+Offering/8030269.html for the full story.
StreetInsider.com  Dec 20  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Arrowhead+Research+Corp.+%28ARWR%29+Reports+Q4+Loss+of+%240.43/7964459.html for the full story.
StreetInsider.com  Dec 18  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Arrowhead+%28ARWR%29+and+Shire+Team+to+Develope+and+Commercialize+Peptide-Targeted+Therapeutics/7955104.html for the full story.
StreetInsider.com  Dec 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Arrowhead+Research+%28ARWR%29+Prices+1.8M+Offering+at+%242.26Unit/7932065.html for the full story.
Benzinga  Dec 6  Comment 
Arrowhead Research Corporation (NASDAQ: ARWR) today announced that it intends to offer units consisting of shares of common stock and warrants in a public offering. Dawson James Securities, Inc. will serve as the sole book-running manager for the...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki